CRINETICS PHARMACEUTICALS INC. - COMMON STOCK
53.14
04-10月-24 14:59:59
15 分の遅延
株式
+0.37
+0.70%
本日の幅
52.73 - 53.59
ISIN
N/A
ソース
NASDAQ
-
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
26 9 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
10 9 2024 15:40:25 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Participate in Two Upcoming Investor Conferences
29 8 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
12 8 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
08 8 2024 15:05:01 提供 Nasdaq GlobeNewswire
-
08 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024
18 7 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces July 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 7 2024 18:29:44 提供 Nasdaq GlobeNewswire
-
18 6 2024 15:30:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces June 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 6 2024 17:35:30 提供 Nasdaq GlobeNewswire
-
03 6 2024 11:00:00 提供 Nasdaq GlobeNewswire
-
30 5 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces Early Release of ENDO 2024 Late-Breaking Abstracts
22 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 5 2024 16:38:21 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
09 5 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
08 5 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
02 5 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
11 4 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
19 3 2024 05:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >